European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 122-128 , March 2008

Health-related quality of life in patients with systemic lupus erythematosus and its relationship with cyclophosphamide pulse therapy

  • Marta Maria C. Medeiros

      Affiliations

    • Adjunct Professor of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
    • Corresponding Author InformationCorresponding author. Rua Paula Ney 599/302. Fortaleza, Ceará, CEP: 60140-200, Brazil. Tel.: +085 32441353; fax: +085 32247222.
    • ,
  • Ana Paula T. Menezes

      Affiliations

    • Division of Rheumatology, Walter Cantídio University Hospital, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
    • ,
  • Virgínia Angélica Silveira

      Affiliations

    • Division of Rheumatology, Walter Cantídio University Hospital, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
    • ,
  • Fernanda Nogueira H. Ferreira

      Affiliations

    • Division of Rheumatology, Walter Cantídio University Hospital, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
    • ,
  • George Rafael Lima

      Affiliations

    • Resident of Walter Cantídio University Hospital, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
    • ,
  • Rozana Mesquita Ciconelli

      Affiliations

    • Associate Professor of Rheumatology, Division of Rheumatology, Federal University of São Paulo, Escola Paulista de Medicina, São Paulo, Brazil

Received 3 October 2006 ,Revised 19 April 2007 ,Accepted 12 June 2007.

References 

  1. Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol. 1999;26:1694–1700
  2. Perez-Cuevas JB, Formiga F, Garcia-Carraco M, Ramos M, Lara C, Rojas-Rodriguez J. A quality of life study in women with systemic lupus erythematosus and its relation to disease activity. An Med Interna. 1999;16(9):457–460
  3. Sutcliffe N, Clarke AE, Levinton C, Frost C, Gordon C, Isenberg DA. Associates of health status in patients with SLE. J Rheumatol. 1999;26:2352–2356
  4. Alarcón GS, McGwin G, Uribe A, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51(3):465–474
  5. Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004;43(12):1580–1586
  6. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol. 1996;14(3):305–308
  7. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997;24:1608–1614
  8. Saba J, Quinet RJ, Davis WE, et al. Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM). Jt Bone Spine. 2003;70(5):348–351
  9. Rupert N, Buratti S, Duarte-Salazar C, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthrtitis Rheum. 2004;51(3):458–464
  10. Greco CM, Rudy TE, Manzi S. Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus. J Rheumatol. 2004;31(2):260–267
  11. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?. Lupus. 2004;13(12):924–926
  12. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med. 1987;83:877–885
  13. Gourley MF, Austin HA, Scott D. Methylprednisolone and cyclophosphamide alone or in combination in patients with lupus nephritis. A randomized controlled trial. An Intern Med. 1996;125(7):549–557
  14. Dooley MA, Falk RJ. Immunosuppressive therapy of lupus nephritis. Lupus. 1998;7:630–634
  15. Takada K, Illei GO, Boumpas DJ. Cyclophosphamide for the treatment of lupus erythematosus systemic. Lupus. 2001;10(3):154–161
  16. Fraenkel L, Bogardus S, Concato J. Patients preferences for treatment of lupus nephritis. Arthritis Rheum. 2002;47(4):421–428
  17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725
  19. Urowitz MB, Gladman DD, Tozman EC, Goldsmith CH. The Lupus Activity Criteria Count (LACC). J Rheumatol. 1984;11(6):783–787
  20. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36. Rev Bras Reumatol. 1999;39(3):143–150
  21. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus. Lupus. 1996;5(3):190–195
  22. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute. New England Medical Centre. 1994;
  23. Ware J, Kosinski M, Bayliss M, Rogers WH, Raczec A. Comparison of methods for the scoring and statistical analysis of SF-36 Health Profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(4):AS264–AS279
  24. Mari JJ, Williams P. A comparison of the validity of two psychiatric screening questionnaires (GHQ-12 and SRQ-20) in Brazil, using relative operating characteristic (ROC) analysis. Psychol Med. 1985;15(3):651–659
  25. StataCorp Stata Statistical Software: release 7.0. Stata Corporation, 2001.
  26. Gladman D, Urowitz M, Fortin P, et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in Systemic Lupus Erythematosus. Systemic Lupus International Collaborating Clinics Group. J Rheumatol. 1996;23:1953–1955
  27. Freire EA, Maia IO, Nepomuceno JCA, Ciconelli RM. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil. Clin Rheum. 2007;26:423–428
  28. Ferraz MB. Avaliação da qualidade de vida em pacientes com Lupus Eritematoso com manifestações cutâneas. São Paulo: UNIFESP (Tese); 2001;
  29. Meinão IM. Utilização de Recursos e Custos em pacientes com Lupus Eritematoso Sistêmico. São Paulo: UNIFESP (Tese); 2001;
  30. D´Amorim AB. Avaliação das formas auto-administrativas dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. São Paulo: UNIFESP (Tese); 2001;
  31. Vu TV, Escalante A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol. 1999;26:2595–2601
  32. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001;28:525–532
  33. Bae SC, Hashimoto H, Karlson EW, Liang MH, Daltroy LH. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol. 2001;28:1245–1251
  34. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:47–56
  35. Panopalis P, Petri M, Manzi S, et al. The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being. Rheumatology. 2005;44:751–755
  36. Rood MJ, Borggreve SE, Huizinga TW. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. J Rheumatol. 2000;27(8):2057–2059
  37. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 1998;7:101–107

PII: S0953-6205(07)00346-9

doi: 10.1016/j.ejim.2007.06.012

European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 122-128 , March 2008

Article Tools